APOE genotypes modify the obesity paradox in dementia  Journal of Neurology, Neurosurgery and Psychiatry. 2023;94(9):670-680
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37414536
Bariatric surgery and COVID-19 outcomes: a systematic review and meta-analysis  Surgery for Obesity and Related Diseases. 2023;19(9):1058-1066
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37149418
CagriSema and the link between obesity and type 2 diabetes  Lancet. 2023;402(10403):671-673
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37364591
Current and emerging medications for the management of obesity in adults  Medical Journal of Australia. 2023;219(4):188
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37402483
Current and emerging medications for the management of obesity in adults  Medical Journal of Australia. 2023;219(4):187
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37402484
Diagnosis and prevalence of sarcopenic obesity in patients with colorectal cancer: A scoping review  Clinical Nutrition. 2023;42(9):1595-1601
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37480796
Digital services to enable easier access to weight management support. 2023
https://www.nice.org.uk/news/article/digital-services-to-enable-easier-access-to-weight-management-support
The effect of obesity on the mortality of hospitalized adults with COVID-19 considering the human development index: A systematic review and meta-analysis  Obesity Reviews. 2023;24(9):e13591
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37341377
The effects of exercise training on insulin resistance in children and adolescents with overweight or obesity: a systematic review and meta-analysis  Frontiers in Endocrinology. 2023;14:1178376
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37635963
Higher circulating levels of proneurotensin are associated with increased risk of incident NAFLD  Journal of Internal Medicine. 2023;294(3):336-346
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37157165
Obesity and Heart Failure  New England Journal of Medicine. 2023;389(9):e15
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37622667
Obesity and temporomandibular joint disorders: a systematic review and meta-analysis  BMC Oral Health. 2023;23(1):607
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37644424
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial  Lancet. 2023;402(10403):705-719
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37385278
Prenatal and childhood exposure to per-/polyfluoroalkyl substances (PFASs) and its associations with childhood overweight and/or obesity: a systematic review with meta-analyses  Environmental Health: A Global Access Science Source. 2023;22(1):56
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37580798
Should the Six-Minute Walk Test Be Added to the Vital Signs? Why Is Walking so Beneficial? Obesity Paradox?  American Journal of Cardiology. 2023;201:359-361
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37438224
The skeletal and dental age advancements of children and adolescents with overweight and obesity: A systematic review and meta-analysis  American Journal of Orthodontics and Dentofacial Orthopedics. 2023;164(3):325-339
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37367707
A systematic review of economic evaluations of interventions targeting childhood overweight and obesity  Obesity Reviews. 2023;24(9):e13597
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37463862
A systematic review of economic evidence for community-based obesity prevention interventions in children  Obesity Reviews. 2023;24(9):e13592
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37308321
A systematic review of the impact of 7-keto-DHEA on body weight  Archives of Gynecology and Obstetrics. 2023;308(3):777-785
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=36566478
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial  Lancet. 2023;402(10402):613-626
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37385275
Triple G Agonists - A Home Run for Obesity?  New England Journal of Medicine. 2023;389(6):562-563
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37590453
Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial  New England Journal of Medicine. 2023;389(6):514-526
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37366315
Utility of Indices Obtained during Medical Checkups for Predicting Fatty Liver Disease in Non-obese People  Internal Medicine. 2023;62(16):2307-2319
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=36517035
Weight management interventions for adults living with overweight or obesity and severe mental illness: a systematic review and meta-analysis  British Journal of Nutrition. 2023;130(3):536-552
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=36325987
The Weight-loss Effect of GLP-1RAs Glucagon-Like Peptide-1 Receptor Agonists in Non-diabetic Individuals with Overweight or Obesity: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials  American Journal of Clinical Nutrition. 2023;118(3):614-626
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37661106